Print friendly version
Sertoli-leydig cell tumors
Other Names for this Disease
- Androblastoma of ovary
- Arrhenoblastoma
- Arrhenoblastoma of ovary
- Sertoli-leydig cell tumor of the ovary
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Overview
Sertoli-Leydig cell tumors are a cancer that starts in the female ovaries. The cancer cells produce and release a male sex hormone which may cause the development of male physical characteristics (virilization), including facial hair and a deep voice.[1] This type of tumor is sometimes called arrhenoblastoma of the ovary or a stromal tumor.[1][2] Sertoli-Leydig cell tumors are rare tumors which account for less than 0.5% of all ovarian tumors. While they can be found in women of all age groups, they are most common in young women. Treatment involves surgery and chemotherapy or radiation if the cancer has spread. Because Sertoli-Leydig cell tumors have a low chance of spreading, if the tumor is found early, chances for survival are good.[2]
References
- Dugdale DC, Mason JR. Sertoli-Leydig cell tumor. MedlinePlus. http://www.nlm.nih.gov/medlineplus/ency/article/001172.htm. Accessed March 25, 2010.
- Vorvick LJ, Chen YB. Arrhenoblastoma of ovary. MedlinePlus. http://www.nlm.nih.gov/medlineplus/ency/article/001507.htm. Accessed March 25, 2010.
Your Questions Answered
by the Genetic and Rare Diseases Information Center1 question(s) from the public on Sertoli-leydig cell tumors have been answered. See questions and answers. You can also submit a new question.
On this page
General Information
- MedlinePlus, a Web site designed by the National Library of Medicine to help you research your health questions, provides more information about this topic. Click on the link to view this information.
- Medscape Reference provides information on this topic. Click on the link to view this information. You may need to register to view the medical textbook, but registration is free.
- The National Cancer Institute (CIS) provides the most current information on cancer for patients, health professionals, and the general public. You can reach them by calling toll-free at 1-800-422-6237 or by visiting their Web site.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Sertoli-leydig cell tumors. Click on the link to view a sample search on this topic.